ICTS

2nd Open call 2024 for preferential access to the ICTS NANBIOSIS

NANBIOSIS opens in June the 2nd competitive open call 2024 for our “Cutting-Edge Biomedical Solutions” and services.

Our publicly funded facilities and internationally renowned scientist will help you design and test biomedical solutions to your heart’s content. We are open to all interested national and international users who may come either from the public or the private sector. You can apply to use our services in two modalities: under the “Competitive Open Access” (within two designated calls) or by “Access on Demand”, your choice.

To make that happen, at least 20% of the NANBIOSIS Units’ capacity is granted on the Competitive Open Access modality. The proposals granted under this modality will be prioritized according to criteria of scientific and technical quality and singularity. In addition, a 5% discount will be applied for those proposals that resort to at least one of our integrated services, the Cutting-Edge Biomedical Solutions.

NANBIOSIS is a research infrastructure for Biomedicine in which three cutting-edge public institutions collaborate forming a deeply interconnected laboratory network: CIBER-BBN, CCMIJU and IBIMA-Plataforma BIONAND. In addition, NANBIOSIS is part of the Spanish Map of ICTS (Spanish for “Scientific and Technical Unique Infrastructures”), approved by the Spanish Ministerio de Ciencia, Innovación y Universidades .

There are 2 calls per year for Competitive Open Access that allow the prioritization of the best proposals. Click here to apply.

The next call will open on June 1st. The applications can be submitted throughout the whole month (due date June 30th). Access application forms submitted after that date will be processed under the “Access on Demand” modality.

Proposals granted in the Competitive Open Access modality must meet, at least, one of the circumstances listed in the access application form (“order request“), in order to demonstrate their scientific and technical quality or singularity.

Thus, for example, applications related to R&D projects funded through national or European calls are eligible. In addition, the proposals are required to use one of the NANBIOSIS “Cutting-Edge Biomedical Solutions”. That implies the interaction of at least two of our Units, which can be modified to your specific needs.

NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:

1st Open call 2024 for preferential access to the ICTS NANBIOSIS

NANBIOSIS opens in February the 1st competitive open call 2024 for its “Cutting-Edge Biomedical Solutions” and services.

NANBIOSIS is a research infrastructure for Biomedicine in which three cutting-edge public institutions collaborate forming a deeply interconnected laboratory network: CIBER-BBN, CCMIJU and IBIMA-Plataforma BIONAND. In addition, NANBIOSIS is part of the Spanish Map of ICTS (Spanish for “Scientific and Technical Unique Infrastructures”), approved by the Spanish Ministerio de Ciencia, Innovación y Universidades .

Our publicly funded facilities and internationally renowned scientist will help you design and test biomedical solutions to your heart’s content. We are open to all interested national and international users who may come either from the public or the private sector. You can apply to use our services in two modalities: under the “Competitive Open Access” (within two designated calls) or by “Access on Demand”, your choice.

To make that happen, at least 20% of the NANBIOSIS Units’ capacity is granted on the Competitive Open Access modality. The proposals granted under this modality will be prioritized according to criteria of scientific and technical quality and singularity. In addition, a 5% discount will be applied for those proposals that resort to at least one of our integrated services, the Cutting-Edge Biomedical Solutions.

There are 2 calls per year for Competitive Open Access that allow the prioritization of the best proposals. Click here to apply.

The next call will open on February 1st. The applications can be submitted throughout the whole month (due date February 29th). Access application forms submitted after that date will be processed under the “Access on Demand” modality.

Proposals granted in the Competitive Open Access modality must meet, at least, one of the circumstances listed in the access application form (“order request“), in order to demonstrate their scientific and technical quality or singularity.

Thus, for example, applications related to R&D projects funded through national or European calls are eligible. In addition, the proposals are required to use one of the NANBIOSIS “Cutting-Edge Biomedical Solutions”. That implies the interaction of at least two of our Units, which can be modified to your specific needs.

NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:

2nd Open call 2023 for preferential access to the NANBIOSIS ICTS

NANBIOSIS opens in June the 2nd competitive open call 2023 for its “Cutting-Edge Biomedical Solutions” and services.

NANBIOSIS is a Research Infrastructure for Biomedicine made up of the Platforms of the Center for Centro de Ivesntigación Biomedica en Red (CIBER- in the area of Bioengineering, Biomaterials, and Nanomedicine -CIBER-BBN), the Preclinical Infrastructure and the Development of Minimally Invasive Technologies, of the Jesús Usón Minimally Invasive Surgery Center (CCMIJU) and the Nanoimaging unit of the Biomedical Research Institute of Malaga-Nanomedicine Platform (IBIMA-BIONAND Platform).

NANBIOSIS as part of the Spanish Map of ICTS (an acronym for “Scientific and Technical Unique Infrastructures” in Spanish), approved by the Ministry of Science and Innovation, is open to all interested national and international users who may come either from the public or the private sector, and who can apply for access under the “Competitive Open Access” or “Access on Demand” modalities.

The 20% of the NANBIOSIS Units’ capacity is granted on the Competitive Open Access modality and will be prioritized according to criteria of scientific and technical quality and singularity of the proposals.

There are 2 calls per year for open and competitive access that allow the prioritisation of the best service proposals. https://www.nanbiosis.es/call/

The 2nd call of 2023 will open on June 1 and applications can be submitted throughout the whole month (due date June 30^th). Access application forms submitted after that date will be processed as “access on demand” applications.

Proposals granted in the open and competitive access modality must meet, at least, one of the circumstances listed in the access application form (“order request“), in order to demmonstrate their scientifc and technical quality or singularity.

Thus, for example, applications related to R&D projects funded through national or European calls are eligible, as well as the need to carry out one of the NANBIOSIS “Cutting-Edge Biomedical Solutions” that implies the interaction of several Units, among others.

Related news:

1st Open call 2023 for preferential access to the ICTS NANBIOSIS

1st Open call 2023 for preferential access to the ICTS NANBIOSIS

NANBIOSIS opens in February the 1st competitive open call 2023 for its “Cutting-Edge Biomedical Solutions” and services.

NANBIOSIS is a Research Infrastructure for Biomedicine made up of the Platforms of the Center for Centro de Ivesntigación Biomedica en Red (CIBER- in the area of Bioengineering, Biomaterials, and Nanomedicine -CIBER-BBN), the Preclinical Infrastructure and the Development of Minimally Invasive Technologies, of the Jesús Usón Minimally Invasive Surgery Center (CCMIJU) and the Nanoimaging unit of the Biomedical Research Institute of Malaga-Nanomedicine Platform (IBIMA-BIONAND Platform).

NANBIOSIS as part of the Spanish Map of ICTS (an acronym for “Scientific and Technical Unique Infrastructures” in Spanish), approved by the Ministry of Science and Innovation, is open to all interested national and international users who may come either from the public or the private sector, and who can apply for access under the “Competitive Open Access” or “Access on Demand” modalities.

The 20% of the NANBIOSIS Units’ capacity will be granted on the Competitive Open Access modality and will be prioritized according to criteria of scientific and technical quality and singularity of the proposals.

There will be 2 calls per year for open and competitive access that will allow the prioritisation of the best service proposals. Here you have the details of the first call: https://www.nanbiosis.es/call/

The call will open on February 1 and applications can be submitted throughout the whole month (due date February 28^th). Access application forms submitted after that date will be processed as “access on demand” applications.

Proposals granted in the open and competitive access modality must meet, at least, one of the circumstances listed in the access application form (“order request“), in order to demmonstrate their scientifc and technical quality or singularity.

Thus, for example, applications related to R&D projects funded through national or European calls are eligible, as well as the need to carry out one of the NANBIOSIS “Cutting-Edge Biomedical Solutions” that implies the interaction of several Units, among others.